Pentamidine

Role

Indications

Reactions

Primary

Antibiotic Prophylaxis	100.0%

Pancreatitis	100.0%

Secondary

Hiv Infection	25.0%
Immunosuppression	11.8%
Drug Use For Unknown Indication	9.2%
Immunosuppressant Drug Therapy	5.3%
Meningoencephalitis Amoebic	5.3%
Mycobacterium Avium Complex Infection	5.3%
Antibiotic Prophylaxis	3.9%
Antifungal Prophylaxis	3.9%
Pain	3.9%
Pneumocystis Jiroveci Pneumonia	3.9%
Vitamin Supplementation	3.9%
Clostridium Test Positive	2.6%
Non-small Cell Lung Cancer	2.6%
Opportunistic Infection Prophylaxis	2.6%
Product Used For Unknown Indication	2.6%
Rheumatoid Arthritis	2.6%
Anaemia	1.3%
Aspergillosis	1.3%
Blood Cholesterol Increased	1.3%
Blood Lactate Dehydrogenase Increased	1.3%

Mycobacterium Avium Complex Infection	13.6%
Pneumonitis	9.1%
Type 1 Diabetes Mellitus	9.1%
White Blood Cell Count Decreased	9.1%
Abdominal Pain	4.5%
Bone Marrow Failure	4.5%
Bronchospasm	4.5%
Colectomy Total	4.5%
Drug Hypersensitivity	4.5%
Electrocardiogram Qt Prolonged	4.5%
Malaise	4.5%
Pancreatitis	4.5%
Renal Tubular Disorder	4.5%
Respiratory Arrest	4.5%
Reversible Posterior Leukoencephalopathy Syndrome	4.5%
Transplant Rejection	4.5%
Tremor	4.5%

Concomitant

Product Used For Unknown Indication	29.2%
Acute Lymphocytic Leukaemia	14.5%
Hiv Infection	11.5%
Prophylaxis	6.0%
Chromosome Analysis Abnormal	5.3%
Antifungal Prophylaxis	5.1%
Drug Use For Unknown Indication	2.8%
Graft Versus Host Disease	2.7%
Diffuse Large B-cell Lymphoma	2.5%
Pneumocystis Jiroveci Pneumonia	2.5%
Prophylaxis Against Graft Versus Host Disease	2.2%
Infection Prophylaxis	2.0%
Antiviral Prophylaxis	1.9%
Multiple Myeloma	1.9%
Antibiotic Prophylaxis	1.8%
Diarrhoea	1.7%
Hypertension	1.7%
Acute Myeloid Leukaemia	1.6%
Stem Cell Transplant	1.6%
Nausea	1.6%

Renal Failure	11.7%
Weight Decreased	10.6%
Vomiting	7.4%
Venoocclusive Liver Disease	6.4%
Pneumocystis Jiroveci Pneumonia	5.3%
Respiratory Failure	5.3%
Sepsis	5.3%
Off Label Use	4.3%
Staphylococcal Infection	4.3%
Tachycardia	4.3%
Thrombocytopenia	4.3%
Varices Oesophageal	4.3%
White Blood Cell Count Decreased	4.3%
Acute Hepatic Failure	3.2%
Cerebral Haemorrhage	3.2%
Gingival Hyperplasia	3.2%
Graft Versus Host Disease	3.2%
Iron Deficiency	3.2%
Photosensitivity Reaction	3.2%
Pleural Effusion	3.2%